Sorting nexin-12 (SNX12)

Sorting nexin-12 (SNX12) is a member of the sorting nexin family characterized by the presence of a phox (PX) domain, which allows binding to phosphoinositides and endosomal membrane association[1][2]. It is expressed at low levels in human tissues and shares high sequence identity with SNX3[1][2]. SNX12 localizes mainly to early endosomes and is involved in the regulation of endosomal subcompartment maturation, the formation of intraluminal vesicles, and the sorting and recycling of specific membrane receptors, such as CIM6PR/IGF2R and the EGF receptor[1][2][3]. Overexpression of SNX12 impedes maturation of multivesicular endosomes, while suppression disrupts endosomal morphology and trafficking[3]. SNX12 interacts with BACE1 and may influence amyloid β production, providing a potential link to Alzheimer’s disease pathology[2]. There are no known drugs or biomarkers currently associated with SNX12 as a pharmacological target, and it is not considered a canonical "therapeutic target" such as a receptor or enzyme in current literature[2][3].

Other names

Sorting nexin 12SNX12sorting nexin-12SNX12_HUMAN